Image Credit: STAT News STAT+: The CRISPR companies are not OK Watchdoq February 6, 2025 Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR is hard to do profitably. Read Full Article
